BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Angsantikul P, Thamphiwatana S, Zhang Q, Spiekermann K, Zhuang J, Fang RH, Gao W, Obonyo M, Zhang L. Coating nanoparticles with gastric epithelial cell membrane for targeted antibiotic delivery against Helicobacter pylori infection. Adv Ther (Weinh) 2018;1:1800016. [PMID: 30320205 DOI: 10.1002/adtp.201800016] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 9.3] [Reference Citation Analysis]
Number Citing Articles
1 Ho D, Wang P, Kee T. Artificial intelligence in nanomedicine. Nanoscale Horiz 2019;4:365-77. [DOI: 10.1039/c8nh00233a] [Cited by in Crossref: 30] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
2 Yang G, Chen S, Zhang J. Bioinspired and Biomimetic Nanotherapies for the Treatment of Infectious Diseases. Front Pharmacol 2019;10:751. [PMID: 31333467 DOI: 10.3389/fphar.2019.00751] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 8.7] [Reference Citation Analysis]
3 Wang H, Liu Y, He R, Xu D, Zang J, Weeranoppanant N, Dong H, Li Y. Cell membrane biomimetic nanoparticles for inflammation and cancer targeting in drug delivery. Biomater Sci 2020;8:552-68. [PMID: 31769765 DOI: 10.1039/c9bm01392j] [Cited by in Crossref: 49] [Cited by in F6Publishing: 12] [Article Influence: 24.5] [Reference Citation Analysis]
4 Osman N, Devnarain N, Omolo CA, Fasiku V, Jaglal Y, Govender T. Surface modification of nano-drug delivery systems for enhancing antibiotic delivery and activity. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2021;:e1758. [PMID: 34643067 DOI: 10.1002/wnan.1758] [Reference Citation Analysis]
5 Deusenbery C, Wang Y, Shukla A. Recent Innovations in Bacterial Infection Detection and Treatment. ACS Infect Dis 2021;7:695-720. [PMID: 33733747 DOI: 10.1021/acsinfecdis.0c00890] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
6 Van Giau V, An SSA, Hulme J. Recent advances in the treatment of pathogenic infections using antibiotics and nano-drug delivery vehicles. Drug Des Devel Ther 2019;13:327-43. [PMID: 30705582 DOI: 10.2147/DDDT.S190577] [Cited by in Crossref: 45] [Cited by in F6Publishing: 17] [Article Influence: 15.0] [Reference Citation Analysis]
7 Bi C, Xiao G, Liu C, Yan J, Chen J, Si W, Zhang J, Liu Z. Molecular Immune Mechanism of Intestinal Microbiota and Their Metabolites in the Occurrence and Development of Liver Cancer. Front Cell Dev Biol 2021;9:702414. [PMID: 34957088 DOI: 10.3389/fcell.2021.702414] [Reference Citation Analysis]
8 Song W, Anselmo AC, Huang L. Nanotechnology intervention of the microbiome for cancer therapy. Nat Nanotechnol 2019;14:1093-103. [DOI: 10.1038/s41565-019-0589-5] [Cited by in Crossref: 45] [Cited by in F6Publishing: 37] [Article Influence: 15.0] [Reference Citation Analysis]
9 Schwartz-Duval AS, Wen R, Srivastava I, Moitra P, Pan D. A Simplistic Single-Step Method for Preparing Biomimetic Nanoparticles from Endogenous Biomaterials. ACS Appl Mater Interfaces 2021;13:46464-77. [PMID: 34569780 DOI: 10.1021/acsami.1c17302] [Reference Citation Analysis]
10 Jiang Y, Chekuri S, Fang RH, Zhang L. Engineering biological interactions on the nanoscale. Curr Opin Biotechnol 2019;58:1-8. [PMID: 30390535 DOI: 10.1016/j.copbio.2018.10.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
11 Karmakar P, Gaitonde V. Promising Recent Strategies with Potential Clinical Translational Value to Combat Antibacterial Resistant Surge. Medicines (Basel) 2019;6:E21. [PMID: 30709019 DOI: 10.3390/medicines6010021] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
12 de Souza MPC, de Camargo BAF, Spósito L, Fortunato GC, Carvalho GC, Marena GD, Meneguin AB, Bauab TM, Chorilli M. Highlighting the use of micro and nanoparticles based-drug delivery systems for the treatment of Helicobacter pylori infections. Crit Rev Microbiol 2021;47:435-60. [PMID: 33725462 DOI: 10.1080/1040841X.2021.1895721] [Reference Citation Analysis]
13 Le QV, Lee J, Lee H, Shim G, Oh YK. Cell membrane-derived vesicles for delivery of therapeutic agents. Acta Pharm Sin B 2021;11:2096-113. [PMID: 34522579 DOI: 10.1016/j.apsb.2021.01.020] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
14 Safarov T, Kiran B, Bagirova M, Allahverdiyev AM, Abamor ES. An overview of nanotechnology-based treatment approaches against Helicobacter Pylori. Expert Review of Anti-infective Therapy 2019;17:829-40. [DOI: 10.1080/14787210.2019.1677464] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
15 Zhang Y, Chen Y, Lo C, Zhuang J, Angsantikul P, Zhang Q, Wei X, Zhou Z, Obonyo M, Fang RH, Gao W, Zhang L. Inhibition of Pathogen Adhesion by Bacterial Outer Membrane‐Coated Nanoparticles. Angew Chem 2019;131:11526-30. [DOI: 10.1002/ange.201906280] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
16 Zhang R, Wu S, Ding Q, Fan Q, Dai Y, Guo S, Ye Y, Li C, Zhou M. Recent advances in cell membrane-camouflaged nanoparticles for inflammation therapy. Drug Deliv 2021;28:1109-19. [PMID: 34121563 DOI: 10.1080/10717544.2021.1934188] [Reference Citation Analysis]
17 Sushnitha M, Evangelopoulos M, Tasciotti E, Taraballi F. Cell Membrane-Based Biomimetic Nanoparticles and the Immune System: Immunomodulatory Interactions to Therapeutic Applications. Front Bioeng Biotechnol 2020;8:627. [PMID: 32626700 DOI: 10.3389/fbioe.2020.00627] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
18 Yang B, Fang D, Lv Q, Wang Z, Liu Y. Targeted Therapeutic Strategies in the Battle Against Pathogenic Bacteria. Front Pharmacol 2021;12:673239. [PMID: 34054548 DOI: 10.3389/fphar.2021.673239] [Reference Citation Analysis]
19 Javed I, Cui X, Wang X, Mortimer M, Andrikopoulos N, Li Y, Davis TP, Zhao Y, Ke PC, Chen C. Implications of the Human Gut–Brain and Gut–Cancer Axes for Future Nanomedicine. ACS Nano 2020;14:14391-416. [DOI: 10.1021/acsnano.0c07258] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
20 Raza F, Zafar H, Zhang S, Kamal Z, Su J, Yuan WE, Mingfeng Q. Recent Advances in Cell Membrane-Derived Biomimetic Nanotechnology for Cancer Immunotherapy. Adv Healthc Mater 2021;10:e2002081. [PMID: 33586322 DOI: 10.1002/adhm.202002081] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
21 Gao J, Dong X, Wang Z. Generation, purification and engineering of extracellular vesicles and their biomedical applications. Methods 2020;177:114-25. [PMID: 31790730 DOI: 10.1016/j.ymeth.2019.11.012] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 5.7] [Reference Citation Analysis]
22 Inamura K. Gut microbiota contributes towards immunomodulation against cancer: New frontiers in precision cancer therapeutics. Semin Cancer Biol 2021;70:11-23. [PMID: 32580023 DOI: 10.1016/j.semcancer.2020.06.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
23 Cheng WY, Wu CY, Yu J. The role of gut microbiota in cancer treatment: friend or foe? Gut 2020;69:1867-76. [PMID: 32759302 DOI: 10.1136/gutjnl-2020-321153] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 12.5] [Reference Citation Analysis]
24 Feng R, Yu F, Xu J, Hu X. Knowledge gaps in immune response and immunotherapy involving nanomaterials: Databases and artificial intelligence for material design. Biomaterials 2021;266:120469. [PMID: 33120200 DOI: 10.1016/j.biomaterials.2020.120469] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
25 Wei W, Cheng W, Dai W, Lu F, Cheng Y, Jiang T, Ren Z, Xie Y, Xu J, Zhao Q, Yu X, Yin Y, Li J, Dong H. A Nanodrug Coated with Membrane from Brain Microvascular Endothelial Cells Protects against Experimental Cerebral Malaria. Nano Lett 2021. [PMID: 34967631 DOI: 10.1021/acs.nanolett.1c03514] [Reference Citation Analysis]
26 Su J, Zhang R, Lian Y, Kamal Z, Cheng Z, Qiu Y, Qiu M. Preparation and Characterization of Erythrocyte Membrane-Camouflaged Berberine Hydrochloride-Loaded Gelatin Nanoparticles. Pharmaceutics 2019;11:E93. [PMID: 30813270 DOI: 10.3390/pharmaceutics11020093] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
27 Zhang Y, Chen Y, Lo C, Zhuang J, Angsantikul P, Zhang Q, Wei X, Zhou Z, Obonyo M, Fang RH, Gao W, Zhang L. Inhibition of Pathogen Adhesion by Bacterial Outer Membrane-Coated Nanoparticles. Angew Chem Int Ed Engl 2019;58:11404-8. [PMID: 31206942 DOI: 10.1002/anie.201906280] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 13.3] [Reference Citation Analysis]
28 Meng Z, Zhang Y, Zhou X, Ji J, Liu Z. Nanovaccines with cell-derived components for cancer immunotherapy. Advanced Drug Delivery Reviews 2022. [DOI: 10.1016/j.addr.2021.114107] [Reference Citation Analysis]
29 Wang S, Gao Y, Jin Q, Ji J. Emerging antibacterial nanomedicine for enhanced antibiotic therapy. Biomater Sci 2020;8:6825-39. [DOI: 10.1039/d0bm00974a] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
30 Chugh V, Vijaya Krishna K, Pandit A. Cell Membrane-Coated Mimics: A Methodological Approach for Fabrication, Characterization for Therapeutic Applications, and Challenges for Clinical Translation. ACS Nano 2021. [PMID: 34699181 DOI: 10.1021/acsnano.1c03800] [Reference Citation Analysis]
31 Spanjers JM, Städler B. Cell Membrane Coated Particles. Adv Biosys 2020;4:2000174. [DOI: 10.1002/adbi.202000174] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
32 Rueda-Robles A, Rubio-Tomás T, Plaza-Diaz J, Álvarez-Mercado AI. Impact of Dietary Patterns on H. pylori Infection and the Modulation of Microbiota to Counteract Its Effect. A Narrative Review. Pathogens 2021;10:875. [PMID: 34358024 DOI: 10.3390/pathogens10070875] [Reference Citation Analysis]
33 Zhang L, Xu H, Cheng Z, Wei Y, Sun R, Liang Z, Hu Y, Zhao L, Lian X, Li X, Huang D. Human Cancer Cell Membrane-Cloaked Fe3O4 Nanocubes for Homologous Targeting Improvement. J Phys Chem B 2021;125:7417-26. [PMID: 34185527 DOI: 10.1021/acs.jpcb.1c04383] [Reference Citation Analysis]
34 Gong H, Zhang Q, Komarla A, Wang S, Duan Y, Zhou Z, Chen F, Fang RH, Xu S, Gao W, Zhang L. Nanomaterial Biointerfacing via Mitochondrial Membrane Coating for Targeted Detoxification and Molecular Detection. Nano Lett 2021;21:2603-9. [PMID: 33687220 DOI: 10.1021/acs.nanolett.1c00238] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
35 Yang F, Cabe MH, Ogle SD, Sanchez V, Langert KA. Optimization of critical parameters for coating of polymeric nanoparticles with plasma membrane vesicles by sonication. Sci Rep 2021;11:23996. [PMID: 34907240 DOI: 10.1038/s41598-021-03422-5] [Reference Citation Analysis]
36 Cano A, Ettcheto M, Espina M, López-Machado A, Cajal Y, Rabanal F, Sánchez-López E, Camins A, García ML, Souto EB. State-of-the-art polymeric nanoparticles as promising therapeutic tools against human bacterial infections. J Nanobiotechnology 2020;18:156. [PMID: 33129333 DOI: 10.1186/s12951-020-00714-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
37 Zou S, Wang B, Wang C, Wang Q, Zhang L. Cell membrane-coated nanoparticles: research advances. Nanomedicine (Lond) 2020;15:625-41. [PMID: 32098564 DOI: 10.2217/nnm-2019-0388] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
38 Vijayan V, Mohapatra A, Uthaman S, Park IK. Recent Advances in Nanovaccines Using Biomimetic Immunomodulatory Materials. Pharmaceutics 2019;11:E534. [PMID: 31615112 DOI: 10.3390/pharmaceutics11100534] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 10.3] [Reference Citation Analysis]
39 Yeh YC, Huang TH, Yang SC, Chen CC, Fang JY. Nano-Based Drug Delivery or Targeting to Eradicate Bacteria for Infection Mitigation: A Review of Recent Advances. Front Chem 2020;8:286. [PMID: 32391321 DOI: 10.3389/fchem.2020.00286] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 22.5] [Reference Citation Analysis]
40 Zhu R, Lang T, Yan W, Zhu X, Huang X, Yin Q, Li Y. Gut Microbiota: Influence on Carcinogenesis and Modulation Strategies by Drug Delivery Systems to Improve Cancer Therapy. Adv Sci (Weinh) 2021;8:2003542. [PMID: 34026439 DOI: 10.1002/advs.202003542] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
41 Qin Y, Lao YH, Wang H, Zhang J, Yi K, Chen Z, Han J, Song W, Tao Y, Li M. Combatting Helicobacter pylori with oral nanomedicines. J Mater Chem B 2021;9:9826-38. [PMID: 34854456 DOI: 10.1039/d1tb02038b] [Reference Citation Analysis]
42 Khan S, Sharaf M, Ahmed I, Khan TU, Shabana S, Arif M, Kazmi SSUH, Liu C. Potential utility of nano-based treatment approaches to address the risk of Helicobacter pylori. Expert Rev Anti Infect Ther 2021;:1-18. [PMID: 34658307 DOI: 10.1080/14787210.2022.1990041] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]